• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2022 Oct 11;119(41):e2209042119.
doi: 10.1073/pnas.2209042119. Epub 2022 Sep 22.
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins


Fengwen Zhang[SUP] 1 [/SUP], Trinity M Zang[SUP] 1 [/SUP], Eva M Stevenson[SUP] 2 [/SUP], Xiao Lei[SUP] 1 [/SUP], Dennis C Copertino[SUP] 2 [/SUP], Talia M Mota[SUP] 2 [/SUP], Julie Boucau[SUP] 3 [/SUP], Wilfredo F Garcia-Beltran[SUP] 3 4 [/SUP], R Brad Jones[SUP] 2 [/SUP], Paul D Bieniasz[SUP] 1 5 [/SUP]



Affiliations

Abstract

Viruses employ a variety of strategies to escape or counteract immune responses, including depletion of cell surface major histocompatibility complex class I (MHC-I), that would ordinarily present viral peptides to CD8[SUP]+[/SUP] cytotoxic T cells. As part of a screen to elucidate biological activities associated with individual severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) viral proteins, we found that ORF7a reduced cell surface MHC-I levels by approximately fivefold. Nevertheless, in cells infected with SARS-CoV-2, surface MHC-I levels were reduced even in the absence of ORF7a, suggesting additional mechanisms of MHC-I down-regulation. ORF7a proteins from a sample of sarbecoviruses varied in their ability to induce MHC-I down-regulation and, unlike SARS-CoV-2, the ORF7a protein from SARS-CoV lacked MHC-I downregulating activity. A single amino acid at position 59 (T/F) that is variable among sarbecovirus ORF7a proteins governed the difference in MHC-I downregulating activity. SARS-CoV-2 ORF7a physically associated with the MHC-I heavy chain and inhibited the presentation of expressed antigen to CD8[SUP]+[/SUP] T cells. Specifically, ORF7a prevented the assembly of the MHC-I peptide loading complex and caused retention of MHC-I in the endoplasmic reticulum. The differential ability of ORF7a proteins to function in this way might affect sarbecovirus dissemination and persistence in human populations, particularly those with infection- or vaccine-elicited immunity.

Keywords: MHC-I down-regulation; ORF7a; Peptide loading complex; SARS-CoV-2; Sarbecovirus.
 
Back
Top Bottom